BIRC5 and breast carcinoma: In response to NIC treatment, expression of survivin was upregulated in both xenograft and MDA-MB-231 breast cancer cells (Fig. 3c), thus supporting the proposal that NIC provides survival benefit to the cancer cells which led to increased tumor uptake in mice model.